SEC Form 4 · accession 0001567619-18-004869
BLONDER TONGUE LABORATORIES INC · BDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward Rowland Grauch
Officer — Executive Vice President & COO
Period of report
Oct 29, 2018
Accepted (ET)
Oct 31, 2018 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001000683
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1,F2 | $0.88 | Oct 29, 2018 | A | 150,000 | A | — | Oct 29, 2028 | Common Stock par value $0.001 | 150,000 | 150,000 | D |
| Employee Stock Option (right to buy)F1,F3 | $0.88 | Oct 29, 2018 | A | 350,000 | A | — | Oct 29, 2028 | Common Stock par value $0.001 | 350,000 | 350,000 | D |
Explanation of responses
- F1The exercise price equals the fair market value (equal to the average of the high and low selling prices as reported on the NYSE American) of the common stock on October 29, 2018.
- F2This stock option vests (i) with respect to 30,000 shares on each of October 29, 2019 and 2020 and (ii) with respect to 45,000 shares on each of October 29, 2021 and 2022.
- F3This stock option vests (i) with respect to 70,000 shares on each of October 29, 2019 and 2020 and (ii) with respect to 105,000 shares on each of October 29, 2021 and 2022.